April 12, 2021
Monoclonal Antibody Injection Significantly Reduces COVID-19 Progression
Data from a phase 3 clinical trial for REGEN-COV, a combination monoclonal antibody therapy (casirivimab with imdevimab), is part of the NIH-sponsored COVID Prevention Network, co-led by Myron Cohen at UNC-Chapel Hill.